Higher-Sensitivity XF Analysis Solution

Immune Cell Metabolic Analysis Higher-Sensitivity XF Analysis Solution

19.02.2021Editor: Alexander Stark

Agilent Technologies introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis.

Agilent Technologies introduced the Seahorse XF HS Miniplate.
(Source: Agilent)

Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers — this is how Agilent sums up the advantages of the new Seahorse XF HS Miniplate.

Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered cells to build better disease models. Limitations in the quantities of these cells that they can produce, however, restrict these researchers in the types of cellular assays they can perform.

The XF HS Mini is the latest addition to Agilent’s range of Seahorse XF platforms, which analyze mitochondrial respiration, glycolysis, and ATP production in live cells, in real-time. These metabolic measurements enable researchers to better understand cell health, function, and signaling.

The highly sensitive XF HS Mini analyzer offers improved performance and precision, requiring fewer cells per well, an improved more consistent suspension cell workflow, and streamlined analytics. These improvements enable researchers to confidently generate XF data from quantity limited or low respiring cell types, such as immune cells, where measurements were previously not possible.

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:47147400)

Immune Cell Metabolic Analysis Higher-Sensitivity XF Analysis Solution

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Consent to the use of data for promotional purposes